首页>Cellular oncology (Dordrecht, Netherlands)>Low-dose SAHA enhances CD8<sup>+</sup> T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer.
Low-dose SAHA enhances CD8<sup>+</sup> T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer.